Advertisement
Research Article| Volume 2, ISSUE 3, P233-237, July 2013

Download started.

Ok

Myasthenia gravis and neuromyelitis opica: A causal link

Published:February 18, 2013DOI:https://doi.org/10.1016/j.msard.2013.01.003

      Abstract

      Neuromyelitis Optica (NMO) and Myasthenia Gravis (MG) are rare antibody mediated disorders of the central nervous system (CNS) and neuromuscular junction (NMJ) respectively. Both diseases are predominantly mediated by IgG1 antibodies that activate complement. There have been increasing reports of patients who develop both disorders. Given the rarity of both diseases it would seem that these occurrences are not purely coincidental. There is heterogeneity between the cases described in the literature but common trends are observed in patients who develop both disorders. Most patients described are female. Typically the MG precedes the NMO and the majority of patients have undergone thymectomy. Generally, the symptoms of MG are mild but the NMO tends to follow a more aggressive clinical course. The pathogenesis of NMO in combination with MG is unknown, but thymectomy has been implicated in a subset of patients.
      We present the case of a female patient who developed NMO on a background of sero-positive MG and discuss the relevant literature.

      Highlights

      • We describe the case of a female patient with a known diagnosis of seropositive Myasthenia Gravis (MG) who subsequently developed Neuromyelitis Optica (NMO) and discuss the relevant literature.
      • There are increasing reports of patients who develop both MG and NMO and given the rarity of both diseases it would seem that these occurrences are not purely coincidental.
      • The pathogenesis of NMO in combination with MG is unknown but thymectomy has been implicated in a subset of patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Achari A.N.
        • Trontelj J.V.
        • Campos D.J.
        Multiple sclerosis and myasthenia gravis. A case report with single fiber electromyography.
        Neurology. 1976; 26: 544-546
        • Aita J.F.
        • Snyder D.H.
        • Reichl W.
        Myasthenia gravis and multiple sclerosis: an unusual combination of diseases.
        Neurology. 1974; 24: 72-75
        • Antoine J.C.
        • Camdessanché J.P.
        • Absi L.
        • Lassablière F.
        • Féasson L.
        Devic disease and thymoma with anti-central nervous system and antithymus antibodies.
        Neurology. 2004; 62: 978-980
        • Asgari N.
        • Lillevang S.T.
        • Skejoe H.P.B.
        • Falah M.
        • Stenager E.
        • Kyvik K.O.
        A population-based study of neuromyelitis optica in Caucasians.
        Neurology. 2011; 76: 1589-1595
        • Bichuetti D.B.
        • Barros TM de
        • Oliveira E.M.L.
        • Annes M.
        • Gabbai A.A.
        Demyelinating disease in patients with myasthenia gravis.
        Arquivos de Neuro-Psiquiatria. 2008; 66: 5-7
        • Bradl M.
        • Misu T.
        • Takahashi T.
        • Watanabe M.
        • Mader S.
        • Reindl M.
        • et al.
        Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
        Annals of Neurology. 2009; 66: 630-643
        • Chan K.H.
        • Kwan J.S.C.
        • Ho P.W.L.
        • Ho S.L.
        • Chui W.H.
        • Chu A.C.Y.
        • et al.
        Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis.
        Journal of Neuroimmunology. 2010; 227: 178-184
        • Engel A.G.
        • Sakakibara H.
        • Sahashi K.
        • Lindstrom J.M.
        • Lambert E.H.
        • Lennon V.A.
        Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
        Neurology. 1979; 29: 179-188
        • Etemadifar M.
        • Abtahi S.-H.
        • Dehghani A.
        • Abtahi M.-A.
        • Akbari M.
        • Tabrizi N.
        • et al.
        Myasthenia gravis during the course of neuromyelitis optica.
        Case Reports in Neurology. 2011; 3: 268-273
        • Furukawa Y.
        • Yoshikawa H.
        • Yachie A.
        • Yamada M.
        Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population.
        European Journal of Neurology. 2006; 13: 655-658
        • Gerli R.
        • Paganelli R.
        • Cossarizza A.
        • Muscat C.
        • Piccolo G.
        • Barbieri D.
        • et al.
        Long-term immunologic effects of thymectomy in patients with myasthenia gravis.
        Journal of Allergy and Clinical Immunology. 1999; 103: 865-872
        • Gotkine M.
        • Fellig Y.
        • Abramsky O.
        Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
        Neurology. 2006; 67: 881-883
        • Hironishi M.
        • Ishimoto S.
        • Sawanishi T.
        • Miwa H.
        • Kawachi I.
        • Kondo T.
        Neuromyelitis optica following thymectomy with severe spinal cord atrophy after frequent relapses for 30 years.
        Brain and Nerve. 2012; 64: 951-955
        • Ikeda K.
        • Araki Y.
        • Iwasaki Y.
        Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
        Neurology. 2007; 68 ([author reply 1327]): 1326
        • Isbister C.M.
        • Mackenzie P.J.
        • Anderson D.
        • Wade N.K.
        • Oger J.
        Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia.
        Multiple Sclerosis. 2003; 9: 550-553
      1. Jarius S, Paul F, Franciotta D, de Seze J, Münch C, Salvetti M, et al. Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Multiple Sclerosis. Houndmills, Basingstoke, England. (Internet). Available from: 〈http://www.ncbi.nlm.nih.gov/pubmed/22183934〉; 2011 December 19 [accessed 21.12.11].

        • Kay C.S.K.
        • Scola R.H.
        • Lorenzoni P.J.
        • Jarius S.
        • Arruda W.O.
        • Werneck L.C.
        NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy.
        Journal of the Neurological Sciences. 2008; 275: 148-150
        • Kiessling W.R.
        • Pflughaupt K.W.
        • Ricker K.
        • Haubitz I.
        • Mertens H.G.
        Thyroid function and circulating antithyroid antibodies in myasthenia gravis.
        Neurology. 1981; 31: 771-774
        • Kister I.
        • Gulati S.
        • Boz C.
        • Bergamaschi R.
        • Piccolo G.
        • Piccolo G.
        • et al.
        Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy.
        Archives of Neurology. 2006; 63: 851-856
        • Kohsaka M.
        • Tanaka M.
        • Tahara M.
        • Araki Y.
        • Mori S.
        • Konishi T.
        A case of subacute myelitis with anti-aquaporin 4 antibody after thymectomy for myasthenia gravis: review of autoimmune diseases after thymectomy.
        Rinsho Shinkeigaku. 2010; 50: 111-113
        • Leite M.I.
        • Coutinho E.
        • Lana-Peixoto M.
        • Apostolos S.
        • Waters P.
        • Sato D.
        • et al.
        Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.
        Neurology. 2012; 78: 1601-1607
        • Lindsey J.W.
        • Albers G.W.
        • Steinman L.
        Recurrent transverse myelitis, myasthenia gravis, and autoantibodies.
        Annals of Neurology. 1992; 32: 407-409
        • Lindstrom J.M.
        • Engel A.G.
        • Seybold M.E.
        • Lennon V.A.
        • Lambert E.H.
        Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
        Journal of Experimental Medicine. 1976; 144: 739-753
        • Mapelli G.
        • De Palma P.
        • Franco F.
        • Fini M.
        Myasthenia gravis and recurrent retrobulbar optic neuritis: an unusual combination of diseases.
        Ophthalmologica. 1986; 192: 234-237
        • McKeon A.
        • Lennon V.A.
        • Jacob A.
        • Matiello M.
        • Lucchinetti C.F.
        • Kale N.
        • et al.
        Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.
        Muscle and Nerve. 2009; 39: 87-90
        • Meriggioli M.N.
        Myasthenia gravis with anti-acetylcholine receptor antibodies.
        Frontiers of Neurology and Neuroscience. 2009; 26: 94-108
        • Meriggioli M.N.
        • Sanders D.B.
        Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.
        The Lancet Neurology. 2009; 8: 475-490
        • Nakamura M.
        • Nakashima I.
        • Sato S.
        • Miyazawa I.
        • Fujihara K.
        • Itoyama Y.
        Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands.
        Multiple Sclerosis. 2007; 13: 332-335
        • Ogaki K.
        • Hirayama T.
        • Chijiiwa K.
        • Fukae J.
        • Furuya T.
        • Noda K.
        • et al.
        Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis.
        Neurologist. 2012; 18: 76-79
        • O'Riordan J.I.
        • Gallagher H.L.
        • Thompson A.J.
        • Howard R.S.
        • Kingsley D.P.
        • Thompson E.J.
        • et al.
        Clinical, CSF, and MRI findings in Devic's neuromyelitis optica.
        Journal of Neurology, Neurosurgery, and Psychiatry. 1996; 60: 382-387
        • Palace J.
        • Leite I.
        • Jacob A.
        A practical guide to the treatment of neuromyelitis optica.
        Practical Neurology. 2012; 12: 209-214
        • Pittock S.J.
        • Lennon V.A.
        Aquaporin-4 autoantibodies in a paraneoplastic context.
        Archives of Neurology. 2008; 65: 629-632
        • Robertson N.P.
        • Deans J.
        • Compston D.A.
        Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.
        J. Neurol. Neurosurg. Psychiatr. 1998; 65: 492-496
        • Satoyoshi E.
        • Kinoshita M.
        • Nakazato H.
        • Saku A.
        Evaluation of 4 cases with clinical characteristics of myasthenia gravis and multiple sclerosis.
        Rinsho Shinkeigaku. 1975; 15: 888-894
        • Song F.
        • Guan Z.
        • Gienapp I.E.
        • Shawler T.
        • Benson J.
        • Whitacre C.C.
        The thymus plays a role in oral tolerance in experimental autoimmune encephalomyelitis.
        Journal of Immunology. 2006; 177: 1500-1509
        • Suzuki S.
        • Shimoda M.
        • Kawamura M.
        • Sato H.
        • Nogawa S.
        • Tanaka K.
        • et al.
        Myasthenia gravis accompanied by alopecia areata: clinical and immunogenetic aspects.
        European Journal of Neurology. 2005; 12: 566-570
        • Takahashi T.
        • Miyazawa I.
        • Misu T.
        • Takano R.
        • Nakashima I.
        • Fujihara K.
        • et al.
        Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations.
        Journal of Neurology, Neurosurgery, and Psychiatry. 2008; 79: 1075-1078
        • Thorlacius S.
        • Aarli J.A.
        • Riise T.
        • Matre R.
        • Johnsen H.J.
        Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy.
        Acta Neurologica Scandinavica. 1989; 80: 290-295
        • Uzawa A.
        • Mori M.
        • Iwai Y.
        • Kobayashi M.
        • Hayakawa S.
        • Kawaguchi N.
        • et al.
        Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis.
        Journal of Neurological Sciences. 2009; 287: 105-107
        • Vaknin-Dembinsky A.
        • Abramsky O.
        • Petrou P.
        • Ben-Hur T.
        • Gotkine M.
        • Brill L.
        • et al.
        Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?.
        Archives of Neurology. 2011; 68: 1557-1561
        • Waters P.
        • Jarius S.
        • Littleton E.
        • Leite M.I.
        • Jacob S.
        • Gray B.
        • et al.
        Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
        Archives of Neurology. 2008; 65: 913-919
        • Wingerchuk D.M.
        • Lennon V.A.
        • Pittock S.J.
        • Lucchinetti C.F.
        • Weinshenker B.G.
        Revised diagnostic criteria for neuromyelitis optica.
        Neurology. 2006; 66: 1485-1489
        • Wingerchuk D.M.
        • Lennon V.A.
        • Lucchinetti C.F.
        • Pittock S.J.
        • Weinshenker B.G.
        The spectrum of neuromyelitis optica.
        The Lancet Neurology. 2007; 6: 805-815
        • Zifman E.
        • Litmanovitz I.
        • Segal G.
        • Regev R.
        • Watemberg N.
        Marked hypotonia in an infant of a mother with Devic disease.
        Journal of Child Neurology. 2010; 25: 746-747